BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Tuesday reported fourth-quarter earnings of $818.9 million.
On a per-share basis, the Boston-based company said it had net income of $3.15. Earnings, adjusted for stock option expense and pretax expenses, were $3.76 per share.
The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $3.53 per share.
The drugmaker posted revenue of $2.3 billion in the period, also exceeding Street forecasts. Eleven analysts surveyed by Zacks expected $2.29 billion.
For the year, the company reported profit of $3.32 billion, or $12.82 per share. Revenue was reported as $8.93 billion.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights., source Associated Press News